Trial intelligence / Profile preview

Meditoxin vs Botox for Crow's Feet Lines

NCT03317574Phase 3Completed

Sponsor
Medytox Inc.
Start
Aug 2017
Primary completion
Dec 2017
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of Meditoxin in periorbital wrinkles, sponsored by Medytox Inc.. Started Aug 2017; status: completed.

02

Drugs

Meditoxin
03

Conditions

periorbital wrinkles

Beyond the preview

Go deeper on NCT03317574.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03317574.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call